Terug
Dagbereik
€ 80,60
€ 82,33
52-Weeksbereik
€ 65,94
€ 87,89
Volume
3.018.814
50D / 200D Gem.
€ 82,43
/
€ 80,42
Vorige Slotkoers
€ 82,02
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 44,2 | 0,3 |
| P/B | 4,6 | 2,9 |
| ROE % | 10,6 | 3,7 |
| Net Margin % | 17,7 | 3,8 |
| Rev Growth 5Y % | 3,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 96,38
+18.0%
Low: € 87,00
High: € 110,00
Forward K/W
27,6
Forward WPA
€ 2,97
WPA Groei (sch.)
+0,0%
Omzet Sch.
6,7 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,56
€ 4,47 – € 4,63
|
9,7 B | 2 |
| FY2029 |
€ 4,20
€ 4,12 – € 4,27
|
8,9 B | 2 |
| FY2028 |
€ 3,73
€ 3,54 – € 3,92
|
8,1 B | 4 |
Belangrijkste Punten
Revenue grew 3,77% annually over 5 years — modest growth
Earnings declined -74,28% over the past year
ROE of 10,56% — decent returns on equity
Net margin of 17,69% shows strong profitability
Debt/Equity of 0,07 — conservative balance sheet
Generating 1,34B in free cash flow
Groei
Revenue Growth (5Y)
3,77%
Revenue (1Y)11,55%
Earnings (1Y)-74,28%
FCF Growth (3Y)45,63%
Kwaliteit
Return on Equity
10,56%
ROIC11,11%
Net Margin17,69%
Op. Margin26,97%
Veiligheid
Debt / Equity
0,07
Current Ratio3,72
Interest Coverage0,00
Waardering
P/E Ratio
44,20
P/B Ratio4,59
EV/EBITDA27,63
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,55% | Revenue Growth (3Y) | 10,05% |
| Earnings Growth (1Y) | -74,28% | Earnings Growth (3Y) | -12,51% |
| Revenue Growth (5Y) | 3,77% | Earnings Growth (5Y) | -8,07% |
| Profitability | |||
| Revenue (TTM) | 6,07B | Net Income (TTM) | 1,07B |
| ROE | 10,56% | ROA | 7,84% |
| Gross Margin | 78,13% | Operating Margin | 26,97% |
| Net Margin | 17,69% | Free Cash Flow (TTM) | 1,34B |
| ROIC | 11,11% | FCF Growth (3Y) | 45,63% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 3,72 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 44,20 | P/B Ratio | 4,59 |
| P/S Ratio | 7,82 | PEG Ratio | -0,63 |
| EV/EBITDA | 27,63 | Dividend Yield | 0,00% |
| Market Cap | 47,45B | Enterprise Value | 45,21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,07B | 5,44B | 5,01B | 5,38B | 5,23B |
| Net Income | 1,07B | 4,17B | 1,40B | 1,52B | 1,50B |
| EPS (Diluted) | 1,83 | 6,97 | 2,30 | 2,44 | 2,38 |
| Gross Profit | 4,74B | 4,32B | 3,97B | 4,22B | 4,01B |
| Operating Income | 1,64B | 1,38B | 1,43B | 1,70B | 1,61B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,70B | 13,06B | 9,36B | 8,29B | 8,50B |
| Total Liabilities | 3,36B | 2,99B | 2,64B | 2,49B | 2,67B |
| Shareholders' Equity | 10,34B | 10,00B | 6,65B | 5,81B | 5,84B |
| Total Debt | 705,40M | 700,00M | 685,10M | 691,30M | 690,30M |
| Cash & Equivalents | 2,94B | 3,05B | 1,13B | 769,00M | 862,80M |
| Current Assets | 6,74B | 6,29B | 4,04B | 3,10B | 3,18B |
| Current Liabilities | 1,81B | 1,51B | 1,20B | 1,02B | 1,03B |